CD34+Cell Dose Influences Survival after Allogeneic Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide

被引：2
|
作者：
Elmariah, Hany [1 ]
Naqvi, Syeda Mahrukh Hussnain [2 ]
Kim, Jongphil [3 ]
Nishihori, Taiga [4 ]
Mishra, Asmita [1 ]
Perez, Lia [1 ]
Liu, Hien D. [1 ]
Khimani, Farhad [1 ]
Nieder, Michael
Pidala, Joseph [1 ]
Bejanyan, Nelli [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplantat & Cellular Immun, Tampa, FL USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat & Bioinformat, Tampa, FL USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat & Bioinformat, Tampa, FL USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood Marrow Transplant & Cellular Immunothe, Tampa, FL USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-129437
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3329
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Effect of CD34+cell dose on clinical outcomes after allogeneic hematopoietic stem cell transplantation with post-transplant cyclophosphamide
    Pedraza, A.
    Salas, M. Q.
    Rodriguez-Lobato, L. G.
    Charry, P.
    Suarez-Lledo, M.
    Martinez-Cibrian, N.
    Domenech, A.
    Solano, M. T.
    Arcarons, J.
    Llobet, N.
    Cid, J.
    Lozano, M.
    Rosinol, L.
    Gutierrez-Garcia, G.
    Urbano-Ispizua, A.
    Fernandez-Aviles, F.
    Rovira, M.
    Martinez, C.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 400 - 400
  • [2] Impact of infused CD34+stem cell dosing for allogeneic peripheral blood stem cell transplantation with post-transplant cyclophosphamide
    Hany, Elmariah
    Naqvi, Syeda Mahrukh Hussnain
    Kim, Jongphil
    Nishihori, Taiga
    Mishra, Asmita
    Perez, Lia
    Faramand, Rawan
    Lazaryan, Aleksandr
    Liu, Hien D.
    Khimani, Farhad
    Nieder, Michael
    Anasetti, Claudio
    Pidala, Joseph
    Bejanyan, Nelli
    BONE MARROW TRANSPLANTATION, 2021, 56 (07) : 1683 - 1690
  • [3] Impact of infused CD34+ stem cell dosing for allogeneic peripheral blood stem cell transplantation with post-transplant cyclophosphamide
    Hany Elmariah
    Syeda Mahrukh Hussnain Naqvi
    Jongphil Kim
    Taiga Nishihori
    Asmita Mishra
    Lia Perez
    Rawan Faramand
    Aleksandr Lazaryan
    Hien D. Liu
    Farhad Khimani
    Michael Nieder
    Claudio Anasetti
    Joseph Pidala
    Nelli Bejanyan
    Bone Marrow Transplantation, 2021, 56 : 1683 - 1690
  • [4] Effect of CD34+Cell Dose on the Outcomes of Allogeneic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide
    Pedraza, Alexandra
    Queralt Salas, Maria
    Gerardo Rodriguez-Lobato, Luis
    Charry, Paola
    Suarez-Lledo, Maria
    Martinez-Cibrian, Nuria
    Domenech, Ariadna
    Teresa Solano, Maria
    Arcarons, Jordi
    de Llobet, Noemi
    Rosinol, Laura
    Gutierrez-Garcia, Gonzalo
    Fernandez Aviles, Francesc
    Urbano-Ispizua, Alvaro
    Rovira, Montserrat
    Martinez, Carmen
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (03): : 181.e1 - 181.e10
  • [5] Impact of transplanted CD34+cell dose in allogeneic unmanipulated peripheral blood stem cell transplantation
    Sohn, SK
    Kim, JG
    Kim, DH
    Lee, NY
    Suh, JS
    Lee, KB
    BONE MARROW TRANSPLANTATION, 2003, 31 (11) : 967 - 972
  • [6] Higher Infused CD34+Cell Dose Does Not Influence Clinical Outcomes in Allogeneic Peripheral Blood Stem Cell Transplantation Using Post-Transplant Cyclophosphamide in Children with High-Risk Leukemia
    Yoo, Jae Won
    Jo, Suejung
    Kim, Seongkoo
    Lee, Jae Wook
    Chung, Nack-Gyun
    Jeong, Dae-Chul
    Cho, Bin
    BLOOD, 2023, 142
  • [7] Peripheral blood stem cell grafts in allogeneic hematopoietic cell transplantation: It is not all about the CD34+cell dose
    Reshef, Ran
    TRANSFUSION AND APHERESIS SCIENCE, 2021, 60 (01)
  • [8] Impact of transplant CD34+cell dose on outcomes after allogeneic peripheral blood stem cell transplantation from a matched unrelated donor.
    Nakamura, R
    Smith, D
    Parker, P
    Senitzer, D
    Rodriguez, R
    Falk, P
    Fung, H
    Kirschbaum, M
    Kogut, N
    Krishnan, A
    O'Donnell, MR
    Popplewell, L
    Pullarkat, V
    Sahebi, F
    Smith, E
    Snyder, D
    Spielberger, R
    Stein, A
    Zain, J
    Forman, SJ
    Nademanee, A
    BLOOD, 2003, 102 (11) : 488A - 488A
  • [9] Reduced Dose of Post-Transplant Cyclophosphamide for HLA Haploidentical Peripheral Blood Stem Cell Transplantation
    Morishige, Satoshi
    Yamasaki, Yoshitaka
    Oya, Shuki
    Nakamura, Takayuki
    Ymaguchi, Maki
    Aoyama, Kazutoshi
    Seki, Ritsuko
    Mouri, Fumihiko
    Osaki, Koichi
    Nagafuji, Koji
    BLOOD, 2018, 132
  • [10] Reduced post-transplant cyclophosphamide dose with antithymocyte globulin in peripheral blood stem cell haploidentical transplantation
    Dulery, Remy
    Malard, Florent
    Brissot, Eolia
    Banet, Anne
    Sestili, Simona
    Belhocine, Ramdane
    Calabro, Martina
    van de Wyngaert, Zoe
    Bonnin, Agnes
    Ledraa, Tounes
    Legrand, Ollivier
    Labopin, Myriam
    Capderou, Elodie
    Cohen, Ariel
    Ederhy, Stephane
    Mohty, Mohamad
    BONE MARROW TRANSPLANTATION, 2023, 58 (11) : 1215 - 1222
12345